Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
Cancerworld Magazine > resistance

Posts by tag

resistance

7 posts
Large-scale whole genome sequencing identifies six new cancer susceptibility/ resistance  genes
View Post
  • News

Large-scale whole genome sequencing identifies six new cancer susceptibility/ resistance  genes

  • Janet Fricker
  • 8 November 2024

Six previously unreported genes have been revealed to harbour rare germline mutations that associate with cancer risk. The study, published in Nature Genetics, 29 October, identified 34 genes associated with cancer risk, including four novel genes associated with increased cancer…

View Post
Secondhand smoke reduces cisplatin impact on head & neck tumour cells
View Post
  • News

Secondhand smoke reduces cisplatin impact on head & neck tumour cells

  • Janet Fricker
  • 5 April 2024

Secondhand smoke significantly reduced the ability of chemotherapy to kill head and neck cancer cells and increased the cells’ ability to reproduce. The study, published in the International Journal of Molecular Sciences, found that secondhand smoke altered the proteins that…

View Post
New drug breaks through fibrotic tissue in pancreatic cancer
View Post
  • News

New drug breaks through fibrotic tissue in pancreatic cancer

  • Janet Fricker
  • 21 September 2023

A drug targeting scar-like ‘fibrotic’ tissue within tumours shows promise for treating pancreatic ductal adenocarcinoma (PDAC). In the study, reported online in Nature Cancer, 28 August, Australian investigators showed in mouse and human models of PDAC that, when the drug…

View Post
Cracking RAS: It took over 30 years to hit this ubiquitous oncogene – was it worth the wait?
View Post
  • Articles
  • Biology basic

Cracking RAS: It took over 30 years to hit this ubiquitous oncogene – was it worth the wait?

  • Lisa Hutchinson
  • 14 June 2023

RAS oncogenes and their proteins have central roles in almost all cancers, including leukaemias, multiple myelomas, skin cancers and many solid tumours, making the RAS protein family an ideal cancer target. But efforts to develop clinically efficacious drugs to target…

View Post
Immunotherapy: three studies point to potential strategies to improve response
View Post
  • Articles
  • Medicine

Immunotherapy: three studies point to potential strategies to improve response

  • Janet Fricker
  • 10 March 2023

Over the past 10 years, immune checkpoint inhibitors (ICIs) have transformed the therapeutic landscape of cancer, becoming standard treatments for metastatic melanoma, renal cell carcinoma, head and neck cancer, and non-small cell lung cancers (NSCLC). “ICIs have revolutionised care in…

View Post
Tackling drug resistance: how our commensal bacteria can hinder or help
View Post
  • Articles
  • Biology basic

Tackling drug resistance: how our commensal bacteria can hinder or help

  • Rachel Brazil
  • 7 January 2022

Response to therapeutics can differ widely from patient to patient, with some gaining highly significant survival benefits from a therapy that in others elicits no response at all. Patients who respond initially often develop resistance or relapse over time. Not…

View Post
Tackling resistance to anti-EGFR therapies, from challenges to re-challenge
View Post
  • Articles
  • Practice Points

Tackling resistance to anti-EGFR therapies, from challenges to re-challenge

  • Cristina Ferrario
  • 7 January 2020

Since their first approval and use, more than 15 years ago, inhibitors of the Epidermal Growth Factor Receptor (EGFRi) have revolutionized the clinical practice and the prognosis for cancer patients, especially those diagnosed with colorectal (CRC) and lung cancer. These…

View Post
search
CancerWorld #105 Download CancerWorld #104 Download CancerWorld #103 Download CancerWorld #102 Download CancerWorld #101 Download or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • How a Brain-Destroying Protein Became Cancer’s Ally: Alpha-Synuclein Emerges as a New Target in Melanoma
    • 4 July 2025
  • CancerWorld #105 (July 2025)
    • 2 July 2025
  • How a Chicken Egg Model Could Transform Pediatric Cancer Treatment in Canada
    • 20 June 2025
  • Microbiota-Derived Bile Acids as Androgen Receptor Antagonists Enhance Anti-Tumour Immunity
    • 19 June 2025
  • Strategies Needed to Prioritise Screening in Survivors of Childhood Cancer
    • 4 June 2025
Article
  • Suheir Rasul: Protecting Human Dignity
    • 4 July 2025
  • Equity:The Word That Shaped Her Career From The Lab To The White House:The Story Of Catharine Young
    • 4 July 2025
  • Curious, Rejected,Accepted: An ESO Fellow’s Road to Becoming an Oncologist
    • 3 July 2025
Social

Would you follow us ?

Contents
  • Suheir Rasul: Protecting Human Dignity
    • 4 July 2025
  • Equity:The Word That Shaped Her Career From The Lab To The White House:The Story Of Catharine Young
    • 4 July 2025
  • Curious, Rejected,Accepted: An ESO Fellow’s Road to Becoming an Oncologist
    • 3 July 2025
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.